Literature DB >> 15282088

Use of reversed phase HP liquid chromatography to assay conversion of N-acylglycines to primary fatty acid amides by peptidylglycine-alpha-amidating monooxygenase.

Tara Carpenter1, Derek D Poore, Andrew J Gee, Pallavi Deshpande, David J Merkler, Mitchell E Johnson.   

Abstract

Primary fatty acid amides (R-CO-NH2) and N-acylglycines (R-CO-NH-CH2-COOH) are classes of compounds that have only recently been isolated and characterized from biological sources. Key questions remain regarding how these lipid amides are produced and degraded in biological systems. Relative to the fatty acids, little has been done to develop methods to separate and quantify the fatty acid amides and N-acylglycines. We describe reversed phase HPLC methods for the separation of C2-C12 primary fatty acid amides and N-acylglycines and also C12-C22 fatty acid amides. Separation within each class occurs primarily on the basis of simple interactions between the acyl chain and the chromatographic stationary phase, but the polar headgroups on these and related fatty acids and N-acylethanolamides modulate the absolute retention in reversed phase mode. We use these methods to measure the enzyme-mediated, two-step conversion of N-octanoylglycine to octanoamide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282088     DOI: 10.1016/j.jchromb.2004.05.028

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Common Metabolites in Two Different Hypertensive Mouse Models: A Serum and Urine Metabolome Study.

Authors:  Gaurav Baranwal; Rachel Pilla; Bethany L Goodlett; Aja K Coleman; Cristina M Arenaz; Arul Jayaraman; Joseph M Rutkowski; Robert C Alaniz; Brett M Mitchell
Journal:  Biomolecules       Date:  2021-09-21

2.  Tissue storage affects lipidome profiling in comparison to in vivo microsampling approach.

Authors:  Anna Roszkowska; Miao Yu; Vincent Bessonneau; Leslie Bragg; Mark Servos; Janusz Pawliszyn
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.